438 related articles for article (PubMed ID: 16964426)
1. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
4. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
5. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
6. Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles.
Shigematsu T; Kamura T; Saito T; Kaku T; Nakano H; Kinugawa N
Gynecol Oncol; 1998 Dec; 71(3):376-80. PubMed ID: 9887234
[TBL] [Abstract][Full Text] [Related]
7. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
8. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
9. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
11. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
Kamariah K; Satgunasingam N; Nasri NM; Ng KY
Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
[TBL] [Abstract][Full Text] [Related]
12. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
13. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
Lertkhachonsuk R; Limpongsanurak S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
[TBL] [Abstract][Full Text] [Related]
14. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
15. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
[TBL] [Abstract][Full Text] [Related]
16. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
17. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
[TBL] [Abstract][Full Text] [Related]
18. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
20. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]